dc.contributor.advisor | Baradaran, Behzad | |
dc.contributor.advisor | Hajialilo, Mehrzad | |
dc.contributor.author | Shomali, Navid | |
dc.date.accessioned | 2022-11-07T06:28:30Z | |
dc.date.available | 2022-11-07T06:28:30Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.uri | https://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/67619 | |
dc.description.abstract | Ankylosing spondylitis (AS) is progressive immune-mediated arthritis. Persistent autoreactivity of T cells with an up-regulated Survivin expression is strongly implicated in AS immunopathogenesis.
Material and methods: PBMCs were isolated from patients with AS and healthy matched controls using Ficoll-Hypaque. T cells were obtained using the magnetic-activated cell sorting (MACS) method. After that, the expression levels of Survivin, and specific miRNAs were determined using qT-qPCR. Then, the isolated T cells were co-cultured with interleukin (IL)-2 and muromonab-CD3 (OKT-3 to assess the correlation between T lymphocytes' resistance to apoptosis by determining the rate of apoptosis by Flowcytometry assay.
Results: The results showed that Survivin was up-regulated in patients with AS. It was also revealed that microRNAs that directly or indirectly target the Survivin mRNA were dysregulated in patients with AS. It was revealed that T cells obtained from AS patients were more resistant to apoptosis induction than those obtained from healthy people. | en_US |
dc.language.iso | fa | en_US |
dc.publisher | Tabriz University of Medical Sciences, Faculty of Medicine | en_US |
dc.relation.isversionof | https://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/67618 | en_US |
dc.subject | Ankylosing spondylitis | en_US |
dc.subject | Survivin | en_US |
dc.subject | miRNA | en_US |
dc.subject | T cells | en_US |
dc.subject | Apoptosis | en_US |
dc.title | Determination of Survivin expression in patients with Ankylosing Spondylitis and its relation with the survival of autoreactive T lymphocytes and microRNAs related to this pathway following stimulation to enter the activation-induced cell death phase (AICD) | en_US |
dc.type | Thesis | en_US |
dc.contributor.supervisor | Sandoghchian Shotorbani, Siamak | |
dc.identifier.docno | 6010624 | en_US |
dc.identifier.callno | 10624 | en_US |
dc.description.discipline | Immunology | en_US |
dc.description.degree | Ph. D | en_US |